Identifies byproducts formed during di-2-pyrazinylmethane synthesis, suggesting potential applications.
Crystalline substances were obtained as byproducts in the synthesis of di-2-pyrazinylmethane. These byproducts are identified as tri-2-pyrazinylmethane, 3-chloro-2,2'-bipyrazine, and 9,9-dipyrazinyl-9H-cyclopentadipyrazine based on their spectroscopic properties. Tri-2-pyrazinylmethane is expected to be used as a precursor to tetra-2-pyrazinylmethane. In addition, the reaction mechanism for the formation of these byproducts is discussed.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: